Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
2.080
-0.050 (-2.35%)
At close: Apr 28, 2026, 4:00 PM EDT
2.090
+0.010 (0.48%)
Pre-market: Apr 29, 2026, 6:35 AM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $201.01 million as of April 29, 2026. Its market cap has increased by 151.45% in one year.
Market Cap
201.01M
Enterprise Value
85.39M
1-Year Change
151.45%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $201.01M, a decrease of -77.38%. That is a compound annual growth rate of -26.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 205.84M | 38.50% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 217.31M |
| MediWound | 213.54M |
| OnKure Therapeutics | 210.46M |
| Enlivex | 206.00M |
| OmniAb | 203.42M |
| Whitehawk Therapeutics | 200.27M |
| Elicio Therapeutics | 199.97M |
| Nkarta | 197.47M |